Expedia (EXPE) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Cantor Fitzgerald Raises Price target on Expedia (EXPE) to $130 Following EPS Beat
July 31, 2015 9:58 AM EDTCantor Fitzgerald reiterated a Buy rating on Expedia (NASDAQ: EXPE), and raised the price target to $130.00 (from $120.00), following 2Q results. Revenue was $1,654M vs. consensus of $1,640M. EPS of $0.89 was above consensus' $0.84.
Analyst Naved Khan commented, "2Q results were comfortably ahead of Street... More
Expedia (EXPE) PT Lifted to $135 at Cowen Post Q2; Organic Room Nights Up To +28%
July 31, 2015 8:06 AM EDTCowen analyst Kevin Kopelman reiterated an Outperform rating and boosted his price target on Expedia (NASDAQ: EXPE) to $135.00 (from $130.00) following Q2 results. The analyst highlighted that organic room nights growth was 28%.
commented, "Room nights accelerated slightly to +28% organic in Q2, vs. +27% in Q4, as... More
Expedia (EXPE) PT Raised to $140 at RBC Capital Following 'Intrinsically Strong' Q2
July 31, 2015 6:38 AM EDTRBC Capital analyst Mark Mahaney reiterated an Outperform rating and raised his price target on Expedia (NASDAQ: EXPE) to $140.00 (from $130.00) following an "intrinsically strong Q2 surprisingly strong, given intra-quarter management public commentary -- with better than expected Bookings, Revenue, EBITDA, EPS, and Room... More



